[99mTc]HYNIC-RGD for imaging integrin αvβ3 expression-Reference-Cited by-同舟云学术

[99mTc]HYNIC-RGD for imaging integrin αvβ3 expression

Published:2006-11 Issue:8 Volume:33 Page:945-952
ISSN:0969-8051
Container-title:Nuclear Medicine and Biology
language:en
Short-container-title:Nuclear Medicine and Biology

Author:

Decristoforo Clemens,Faintuch-Linkowski Bluma,Rey Ana,von Guggenberg Elisabeth,Rupprich Marco,Hernandez-Gonzales Ignacio,Rodrigo Teodoro,Haubner Roland

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Molecular Medicine

Reference27 articles.

1. Peptide targeted imaging of cancer;Riccabona;Cancer Biother Radiopharm,2003

2. Receptor targeting for tumour localisation and therapy with radiopeptides;Heppeler;Curr Med Chem,2000

3. Peptide receptors as molecular targets for cancer diagnosis and therapy;Reubi;Endocr Rev,2003

4. Radiolabeled tracers for imaging of tumour angiogenesis and evaluation of anti-angiogenic therapies;Haubner;Curr Pharm Des,2004

5. αíβ3-Integrin imaging: a new approach to characterize angiogenesis?;Haubner;Eur J Nucl Med Mol Imaging,2006

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EGFR- and Integrin αVβ3-Targeting Peptides as Potential Radiometal-Labeled Radiopharmaceuticals for Cancer Theranostics;International Journal of Molecular Sciences;2024-08-05

2. Elevating theranostics: The emergence and promise of radiopharmaceutical cell‐targeting heterodimers in human cancers;iRADIOLOGY;2024-04

3. Design of a New ^99mTc-radiolabeled Cyclo-peptide as Promising Molecular Imaging Agent of CXCR₄Receptor: Molecular Docking, Synthesis, Radiolabeling, and Biological Evaluation;Current Radiopharmaceuticals;2023-10-25

4. An Overview of Radiolabeled RGD Peptides for Theranostic Applications;Current Radiopharmaceuticals;2023-06

5. New opportunities for RGD-engineered metal nanoparticles in cancer;Molecular Cancer;2023-05-25